SCHEMBL6770161

SCHEMBL6770161

COCCNC(=O)c1cnc(SC)nc1Nc1ccc2cn[nH]c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 9/20 0.47
ALDH1A1 P00352 1/20 0.46
LMNA P02545 2/20 0.44
MAPT P10636 1/20 0.44
RPS6KB1 P23443 1/20 0.44
PDGFRB P09619 1/20 0.44
PDGFRA P16234 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
KDR P35968 2/20 0.43
ROCK2 O75116 1/20 0.43
RET P07949 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
DAPK3 O43293 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6769928 0.93 RPS6KB1 (0.52) SYKALDH1A1LMNAMAPTRPS6KB1
SCHEMBL6608523 0.91 SYK (0.48) SYKLMNAMAPTRPS6KB1PDGFRB
SCHEMBL6777397 0.88 SYK (0.46) SYKLMNAMAPTRPS6KB1PDGFRB
SCHEMBL6769860 0.85 SYK (0.52) SYKLMNAMAPTRPS6KB1PDGFRB
SCHEMBL20354302 0.85 SYK (0.52) SYKALDH1A1LMNAMAPTRPS6KB1
SCHEMBL6766170 0.84 KDR (0.46) SYKALDH1A1RPS6KB1PDGFRBPDGFRA
SCHEMBL761284 0.83 SYK (0.54) SYKRPS6KB1PDGFRBPDGFRAMAPK1
SCHEMBL6610211 0.83 SYK (0.55) SYKALDH1A1MAPTRPS6KB1PDGFRB
SCHEMBL6770452 0.83 RPS6KB1 (0.51) SYKLMNAMAPTRPS6KB1MAPK1
SCHEMBL6769391 0.83 PDGFRB (0.66) SYKPDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762189-B1 HEPATITIS B VIRUS AND HUMAN IMMUNODEFICIENCY VIRUS ANTIPROLIFERATION AGENTS; REDUCED CHANCE OF TOXICITY, SIDE EFFECTS, AND DEVELOPMENT OF RESISTANT VIRAL STRAINS DONG WHA PHARM. IND. CO., LTD. (KR) 2004-07-13 US disclosed